Overview
- De Luca, A. et al. (2000) Mol. Pharmacol. 57, 268.
- De Luca, A. et al. (1997) Naunyn Schmiedebergs Arch. Pharmacol. 356, 777.
- De Luca, A. et al. (1997) J. Pharmacol Exp. Ther. 282, 93.
- Fenster, P.E. and Comess, K.A. (1986) Pharmacotherapy 6, 1.
- Lehmann-Horn, F. and Jurkat-Rott, K. (1999) Physiol. Rev. 79, 1317.
- Jackson, C.E. et al. (1994) Muscle Nerve 17, 763.
- Campbell, N.P. et al. (1978) Br. J. Clin. Pharmacol. 6, 103.
- Cannon, S.C. (1996) Trends Neurosci. 19, 3.
- Franchini, C. et al. (2003) J. Med Chem. 46, 5238.
- Ruan, Y. et al. (2007) Circulation 116, 1137.
- Alomone Labs Mexiletine hydrochloride inhibits NaV1.4 channels heterologously expressed in Xenopus oocytes.A. Time course of NaV1.4 current amplitude changes as a result of 1 mM Mexiletine hydrochloride (#M-115) application (horizontal bar) for each of the two test pulses. B. Upper panel: Currents were elicited by a double test pulse protocol applied every 10 sec. For the first pulse the holding potential is -120 mV while the second pulse is preceded by 300 ms at 60 mV. Lower panel: Superimposed example current responses to the voltage stimulation before (black) and during application of 1 mM Mexiletine hydrochloride (green).
The clinical term myotonia is used to identify a series of dominant and recessive forms of genetic skeletal muscle diseases characterized by abnormal membrane excitability and delayed muscle relaxation after voluntary contraction. Sodium channel myotonias, paramyotonia congenita, and hyperkaliemic periodic paralysis are due to mutations of the gene coding for the skeletal muscle type of voltage-gated sodium channels1,2.
Mexiletine, an orally effective antiarrhythmic drug of the IB class3-6 with use-dependent sodium channel-blocking properties2,7, is used for the treatment of ventricular arrhythmia8. Also, it is among the few drugs used to reduce or prevent myotonia1,9-11, to treat long QT-3 syndrome12 and to alleviate neuropathic pain13.
Mexiletine demonstrates IC50 values ranging from ~50 μM to ~100 μM and from ~20 μM to ~30 μM for tonic and phasic block, respectively, on single muscle fibers14 and a value of 253 μM in HEK293 cells15.
Mexiletine has a neuroprotective feature against cerebral ischemia, spinal trauma and head trauma5,16-20. In addition, it protects the neuronal tissue against diabetic oxidative damage21.